Fred Alger Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$41.5M Buy
2023
Q1
$15.9M Sell
2022
Q4
$57.3M Buy
2022
Q3
$15.4M Buy
2021
Q1
Sell
2020
Q4
$992K Sell
2020
Q3
$800K Sell
2020
Q2
$2.59M Buy
2020
Q1
$1.98M Buy
2019
Q4
$1.74M Buy
2019
Q3
$241K Buy
2019
Q1
Sell
2018
Q4
$168K Buy